The Public Has Been Forgiving. But Hospitals Got Some Things Wrong.
Mistakes are inevitable. But we can try to do better. More
Mistakes are inevitable. But we can try to do better. More
In Illinois, at least 355 people who live in state-run homes for adults with disabilities have tested positive for the coronavirus. “They don’t know why their family has stopped coming to visit,” a relative said. More
Dr. Rheeda Walker wrote “The Unapologetic Guide to Black Mental Health,” which has seen an increase in popularity amid coronavirus More
Overall, AI’s implementation in everyday clinical care is less common than hype over the technology would suggest. Yet the coronavirus crisis has inspired some hospital systems to accelerate promising applications. More
The hero image burns so bright that it eclipses any light shining on the failures of the system that could turn heroes into involuntary martyrs. More
“Not my problem” is not the right response to the coronavirus. More
Homes with a significant number of black and Latino residents have been twice as likely to be hit by the coronavirus as those where the population is overwhelmingly white. More
Some form of prospective payment is needed, experts say More
Navigating this pandemic is difficult in many ways, but it’s particularly complicated when a loved one has dementia. More
Maine investigators find one patient’s saga with O’NA HealthCare offers a cautionary tale for anyone looking for cut-rate coverage online. More
This randomized clinical trial evaluates the effects of pro-male stereotypes on female surgical residents. More
Women make up 75-80% of health care workers, but only 13% of health care executives. In a new book, Dr. Patty Gabow explains why we should be encouraging more female leadership in health care and provides a guide for aspiring health care leaders. More
Two top FDA officials will recuse themselves from Covid-19 vaccine approval decisions since they are joining a Trump push for approval. More
Remdesivir is the poster child for why we need a new model of drug development for pandemics and neglected diseases that isn't market-based. More
On the eve of New Mexico’s shutdown of bars and restaurants to stem the spread of the coronavirus, the city of Gallup came alive for one last night of revelry. More
Black patients were losing limbs at triple the rate of others. The doctor put up billboards in the Mississippi Delta. Amputation Prevention Institute, they read. He could save their limbs, if it wasn’t too late. More
Without the underlying data, promising vaccines and treatments are impossible to evaluate. More
Congress authorized $100 billion for health care providers, both to compensate them for the extra costs associated with caring for patients with COVID-19 and for the revenue that’s not coming in from regular care. They have been required to stop providing most nonemergency services, and many patients are afraid to visit health care facilities. More
Bedaquiline, an important treatment for tuberculosis, costs too much for most people. Johnson & Johnson could sell it for $1 a day and still turn a profit. More
Allergan’s “medical aesthetics” products helped persuade AbbVie to buy the company. But what if the devices driving profit are also endangering women’s health? More